Drugs / Xingbaiji Formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06848426 | Mar 2025 → Jun 2027 expected | non-small cell lung carcinoma | Jiangxi Provincial People's Hopital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xingbaiji Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06848426 ↗ |
| Route | Oral | “Administration: 1 bag orally, twice daily” NCT06848426 ↗ |